The Ancona plant, located just a few kilometres from one of the most important ports on the Adriatic sea, produces medical specialities that are exported to 67 countries.
It is EU-GMP authorised and can also produce certain high-activity pharmaceuticals such as hormones and non-beta-lactam and non-cephalosporin antibiotics. The Health Ministry has also authorised production of medical and surgical supplies and the use of narcotics and psychotropic substances in the production of medicines. Medical devices can also be manufactured.
The core business of the plant is the production of solids, but non-sterile liquids and semi-solids are also important. A special department produces small batches of pharmaceuticals for clinical trials, even for third parties.
The plant has a series of certifications from the TÜV SÜD in Munich: UNI EN ISO 9001:2015 for the Quality System; UNI EN ISO 13485:2016 for the Quality Management System; UNI EN ISO 14001:2015 for the environment and BS OHSAS 18001:2007 for safety.
An advanced energy saving project has been implemented in the plant. This prize-winning system was designed to reduce energy consumption while maintaining GMP parameters. It exploits favourable external climatic conditions (lower dewpoint) to increase the temperature of the refrigerated water used to control the internal climate. It reduced electricity consumption by about 830 MWh per year, saving about 10,000m3/year of water supplied from the public utility for domestic use (drinkable water).
Of the total surface area of 177,000 m2, more than 15,000 m2 are dedicated to production, 660 m2 to production of experimental pharmaceuticals, 2,340 m2 to laboratories, 5,000 m2 to raw materials and packaging storage, 21,700 m2 to distribution warehousing and 21,650 m2 to office space and systems.